Aurobindo Pharma has reported results for first quarter ended June 30, 2013.
The company has reported a net profit of Rs 143.63 crore for the quarter as compared to a net loss of Rs 49.84 crore for the same quarter in the previous year. Total income of the company has increased by 42.81% at Rs 1614.61 crore for quarter under review as compared to Rs 1130.61 crore for the quarter ended June 30, 2012.
On the consolidated basis, the group registered a net profit after taxes and minority interest at Rs 18.60 crore for the quarter as compared to a net loss of Rs 128.91 crore for the same quarter in the previous year. Total income of the company, on consolidated basis, has increased by 41.33% at Rs 1719.48 crore for quarter under review as compared to Rs 1216.63 crore for the quarter ended June 30, 2012.
